Ohad Karnieli, PhD
Cell Therapy Innovation and Automation Expert
Founder and President of Atvio Biotech, a leading innovation center for cell and gene therapy which was sold to Orgenesis Inc.
VP of Technology & Manufacturing at Pluristem Therapeutics where he lead the process development, product development and GMP manufacturing. During his 5-year term at Pluristem, Dr Karnieli was in charge of the designing, building and operation the company’s state of the art automatic cell therapy manufacturing facility
VP medical device at Goji Solutions developing innovative medical RF based medical devices
PhD, Cell and Gene Therapy; Sackler School of Medicine of Tel Aviv University
MBA; Haifa University